Although the precise mechanisms of ANO1 in glioma progression remain unclear, it was first suggested that ANO1 expression is associated with activation of the nuclear factor-κB (NF-κB) signalling pathway [137]. The gene discussed is NFKB1; the disease is central nervous system cancer.